These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25861000)

  • 1. Use of oral bisphosphonates in primary prevention of fractures in postmenopausal women: a population-based cohort study.
    Real J; Galindo G; Galván L; Lafarga MA; Rodrigo MD; Ortega M
    PLoS One; 2015; 10(4):e0118178. PubMed ID: 25861000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Mignot MA; Taisne N; Legroux I; Cortet B; Paccou J
    Osteoporos Int; 2017 Dec; 28(12):3431-3438. PubMed ID: 28875236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study.
    Warensjö E; Byberg L; Melhus H; Gedeborg R; Mallmin H; Wolk A; Michaëlsson K
    BMJ; 2011 May; 342():d1473. PubMed ID: 21610048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing clinical and economic outcomes of biologic and conventional medications in postmenopausal women with osteoporosis.
    Hernandez I; Zhang Y
    J Eval Clin Pract; 2015 Oct; 21(5):840-7. PubMed ID: 26059485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of osteoporosis drugs in preventing secondary nonvertebral fractures in Taiwanese women.
    Lin TC; Yang CY; Yang YH; Lin SJ
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4717-26. PubMed ID: 24081731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteoporosis].
    Uelbelhart B; Rizzoli R
    Rev Med Suisse; 2012 Jan; 8(324):109-10, 112-5. PubMed ID: 23185820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis.
    Morales-Santana S; Díez-Pérez A; Olmos JM; Nogués X; Sosa M; Díaz-Curiel M; Pérez-Castrillón JL; Pérez-Cano R; Torrijos A; Jodar E; Rio LD; Caeiro-Rey JR; Reyes-García R; García-Fontana B; González-Macías J; Muñoz-Torres M
    Maturitas; 2015 Dec; 82(4):402-10. PubMed ID: 26358930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review.
    Fujiwara S; Miyauchi A; Hamaya E; Nicholls RJ; Weston A; Baidya S; Pinto L; Barron R; Takada J
    Arch Osteoporos; 2018 Mar; 13(1):34. PubMed ID: 29564555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
    Sanfélix-Genovés J; Sanfélix-Gimeno G; Peiró S; Hurtado I; Fluixà C; Fuertes A; Campos JC; Giner V; Baixauli C
    Osteoporos Int; 2013 Mar; 24(3):1045-55. PubMed ID: 22618269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fracture risk after deprescription of bisphosphonates: Application of real-world data in primary care.
    Troncoso-Mariño A; Lestón Vázquez M; Gallardo Borge S; Del Val Garcia JL; Amado Guirado E; Violán C
    Aten Primaria; 2023 Jul; 55(7):102651. PubMed ID: 37187104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.
    Modi A; Tang J; Sen S; Díez-Pérez A
    Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: patterns of use and associated factors.
    Castro-Lionard K; Dargent-Molina P; Fermanian C; Gonthier R; Cassou B
    Drugs Aging; 2013 Dec; 30(12):1029-38. PubMed ID: 24114665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
    Miller PD; Hattersley G; Riis BJ; Williams GC; Lau E; Russo LA; Alexandersen P; Zerbini CA; Hu MY; Harris AG; Fitzpatrick LA; Cosman F; Christiansen C;
    JAMA; 2016 Aug; 316(7):722-33. PubMed ID: 27533157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronic acid increases bone mineral density and improves health-related quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis.
    Huang S; Lin H; Zhu X; Chen X; Fan L; Liu C
    Endokrynol Pol; 2014; 65(2):96-104. PubMed ID: 24802732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective clinical study of once monthly ibandronate in the treatment of osteoporosis and prevention of fractures in postmenopausal women: ORPHEUM Study.
    Bumbasirević M; Lesić A; Denić-Marković L; Zivković K;
    Srp Arh Celok Lek; 2011; 139(11-12):790-4. PubMed ID: 22338477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Promises and fears of osteoporosis treatments].
    Uebelhart B
    Rev Med Suisse; 2013 Jan; 9(371):262. PubMed ID: 23451595
    [No Abstract]   [Full Text] [Related]  

  • 20. [New spine and non-spine fractures in 871 women/year treated with oral pamidronate plus calcium and vitamin D supplements].
    Man Z; Otero AB
    Medicina (B Aires); 1997; 57 Suppl 1():32-6. PubMed ID: 9567352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.